Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health.

Cells · 2023 · PMC10605243 · PMID 37887306

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

During osteogenic differentiation of VSMCs into CVCs, we found a marked borderline significant enrichment of rosiglitazone targets from clusters 1 and 2 ( Figure 5 C), and here also, no significant enrichment for clusters 3 and 4 was observed.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.